Journal of Clinical Psychopharmacology
March 14, 2022
Juliana Mendes Rocha, Giordano Novak Rossi, Flávia L. Osório et al.
11 citations
Psychedelics show promise in treating brain disorders, with a study involving 200 participants revealing a 60% reduction in symptoms of depression and anxiety after a single dose. Tryptophan, a key amino acid, plays a crucial role in serotonin production, which is vital for mood regulation. Biochemical analysis and advanced sensing techniques have enhanced understanding of these substances' effects on the brain, highlighting their potential as innovative therapies for mental health challenges. This groundbreaking approach could reshape treatment paradigms for various conditions.
SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português)
February 1, 2007
Rafael Guimarães Dos Santos
7 citations
This review describes the neurochemical and pharmacological foundations of ayahuasca, a psychoactive preparation used by various indigenous and non-indigenous groups for therapeutic, magical, and religious purposes. It synthesizes existing knowledge on how the beverage's active compounds interact with brain chemistry to produce its effects.
April 8, 2016
Beatriz Caiuby Labate, Rafael Guimarães Dos Santos, Brian Anderson et al.
2 citations
Ayahuasca, used ritually in South American religions such as Santo Daime and União do Vegetal and in Amazonian rehabilitation centers, shows therapeutic potential for treating substance dependence. Anthropological and psychiatric data indicate that ritual ayahuasca use can aid healing from addiction. The chapter reviews evidence from these settings and discusses methodological, ethical, and political considerations for future research. It places current studies in the context of psychedelic and psycholytic therapies developed between the 1950s and 1970s, emphasizing the need for interdisciplinary approaches to understand ayahuasca's role in dependence treatment.